Share Price:

APNASPENAspen Pharmacare Hldgs1967273 (0.37%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

KSA English

Contact Us - KSA English

WHAT IS PHARMACOVIGILANCE?
Science and activities related to the detection, evaluation, understanding and prevention of adverse drug event, including everything related to drug safety.

WHAT IS ADVERSE DRUG EVENT?
Unintended and unwanted symptoms sometimes caused by the use of the right dosage of pharmaceuticals.

Please find the attached reporting form for Adverse Drug Event in PDF format (English):
Click here to download the pdf file

Please find the attached reporting form for Adverse Drug Event in PDF format (Arabic):
Click here to download the pdf file

MEANS OF CONTACTING THE QUALIFIED PERSON FOR PHARMACOVIGILANCE OR HIS DEPUTY:

Qualified Person for Pharmacovigilance:
Ahmed Al Zahrani

Mobile: 053 240 3398
Direct telephone: +966 11 217 1951 Ext: 109
Email: aalzahrani@ae.aspenpharma.com


Deputy of the Qualified Person for Pharmacovigilance:

Abdulaziz Alsuwyeh
Mobile: 055 555 8724
Direct telephone: +966 11 217 1951 Ext: 101
Email: aalsuwyeh@ae.aspenpharma.com
Aspen Saudi PV department email: ahc.pv-saudi@ae.aspenpharma.com

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.